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Purpose: To evaluate the efficacy of releasable single suture (RS) for conjunctival
autograft (CAG) and to compare it with sutureless gluefree (SG) technique in pterygium
surgery.
Methods: We conducted a retrospective comparative study on patients with primary
pterygium who underwent CAG. In 150 patients, CAG was additionally secured by a
single 10-0 nylon releasable suture (RS) which was released on the first postoperative
day. In 47 patients, no suture was applied, and CAG was allowed to stick to the scleral
bed by autologous fibrin only (SG group). The duration of surgery and size of CAG (in
mm2) was noted in both groups. All patients completed one year of follow-up. Factors
that were studied included graft stability, patient comfort, complications, and recurrence.
Results: The mean age of patients in RS and SG groups was 39.6 ± 11.8 and 47.3 ±
13.8 years, respectively. The mean duration of surgery was 4.84 ± 1.34 min in RS group
and 4.90 ± 1.42 min in SG group (P = 0.001). The size of CAG used in both groups was
comparable with more stability in RS group postoperatively. Graft retraction rate in RS
group was 5.3% (1 mm retraction in CAG more than 36 mm2) with no event of graft loss.
The graft loss occurred in 6.3% of eyes in SG group. The recurrence rate in RS group
was 4%, while in SG group it was 6.3% (P = 0.4).
Conclusion: RS, by augmenting the autologous blood mechanism, may offer an easy to
learn option for pterygium surgery with good stability even in large sized CAGs.
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Pterygium is a triangular “wing-like” growth
consisting of conjunctival epithelium and
hypertrophied subconjunctival connective tissue
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that encroaches onto the cornea.[1] The surgical
excision is the treatment of choice, but its propen-
sity for recurrence is a major concern. Switch-
ing from unacceptably high recurrence rate of
bare sclera technique (60–80%)[2] to encouraging
results of conjunctival autograft (CAG) was popu-
larized by Kenyon et al.[3] To date, CAG remains a
time-tested and gold standard treatment with low
recurrence and high stability.[3, 5] But, the debate
over the best approach is focused on whether
surgeons should use sutures or suture-less options
like fibrin glue or autologous fibrin to secure the
CAG.
Fibrin glue has shorter duration of surgery,
better patient comfort, and less chance of recur-
rences (14%) compared to other techniques for CAG
fixation.[4] Important disadvantages are cost and
accessibility. In fibrin-assisted surgery, complica-
tions such as dehiscence, graft retraction, and pyo-
genic granuloma were seen more frequently.[5, 6]
Suture assisted surgery ensures graft stability
with acceptable recurrence rates of 5–15%.[7] The
immediate postoperative patient discomfort with
symptoms of pain, watering, foreign body sensa-
tion, and sub-conjunctival hematoma are its major
disadvantages.[8, 9]
Thus, we proposed a newer suture assisted
technique in which the CAG was secured by a
single 10-0 nylon suture with a releasable knot
and was released on the first postoperative day.
We compared its results with current accepted
standard of autologous blood assisted pterygium
surgery.
METHODS
We conducted a retrospective comparative obser-
vational study at our tertiary eye care center.
Medical records of 197 patients with primary ptery-
gium were reviewed. All methods adhered to the
tenets of The Declaration of Helsinki Principles for
research in human subjects. The treatment groups
were assigned arbitrarily by one of the authors. In
the RS group (n = 150), CAGwas secured by a single
10-0 nylon suture tied with a releasable knot. In
the SG group (n = 47), patients’ own blood from
the surgical area was used as a source of fibrin.
We followed the slit-lamp grading system given by
Tan et al.[10] All patients were operated by a single
surgeon.
Primary outcome measures were graft stability
and recurrence. Secondary outcome measures
were patient comfort in terms of pain on Visual
Analogue Scale (VAS) and best corrected visual
acuity (BCVA).
Descriptive and inferential statistical analy-
sis was carried out in the present study. Chi-
square/Fisher Exact test was used to find the
significance of study parameters on categorical
scale between the two groups. The significance
was assessed at 5% level of significance. The
statistical software namely SPSS 15.0 was used for
the analysis of the data and Microsoft Word and
Excel were used to generate graphs and tables.
Surgical Technique
The body of pterygium was firmly held at limbus
by toothed forceps, and adhesion between the
pterygium and sclera was sharply incised and
separated using conjunctival scissors. The head of
pterygiumwas avulsed from the underlying cornea.
The fibrous tissue was scrapped off by Bard-Parker
15 number blade. Only the fleshy subconjunc-
tival hypertrophied tissue with tortuous vessels
and adjacent thickened conjunctival tissue was
excised. The size of the bare-scleral defect was
measured inmillimeter square (mm2) by Castroviejo
calipers. CAG was taken from superior quadrant
by ballooning the conjunctiva with 0.5 cc dexam-
ethasone (4mg/ml) subconjunctival injection. A thin
tenon-free CAG was prepared. Graft flip was done
with an iris spatula and was transferred to bare
sclera carefully to coincide the limbal to limbal
area and keeping the epithelial side up. Ironing of
the graft was done with two iris spatulas. In RS
group, though the CAG was already stuck to the
underlying bare sclera due to autologous fibrin,
the center of CAG was additionally stabilized (see
Figure 1, showing diagrammatic representation of a
releasable suture (RS) in situ) by single 10-0 nylon
suture tied in a releasable fashion keeping one
end of suture longer than the other (see video,
electronic supplementary material 1, showing the
application of RS). In SG group, bleeding secondary
to excision of vessel-rich tissue was used as a
source of autologous fibrin. Excessive bleeding
was controlled by hemostasis with the help of
sterile Merocel sponge to avoid graft relift. Graft
was examined for apposition. End of surgery was
noted after the removal of the eye speculum.
JOURNAL OF OPHTHALMIC AND VISION RESEARCH VOLUME 15, ISSUE 1, JANUARY-MARCH 2020 33
Suture vs Autologous Blood for Pterygium Surgery; Parmar et al
After 24 h, on the first postoperative day, patient
was examined using a slit-lamp (see Figure 2,
showing preoperative and postoperative slit-lamp
photograph of patient 1). Proparacaine 0.5% eye
drop was used as topical anesthetic agent and
the suture was released at slit-lamp by pulling
the longer end of the 10-0 nylon suture in RS
group; patient was re-examined for graft status,
apposition, and retraction. The VAS with grading
from 1 to 10 was shown and explained to patients,
asking them to report the severity of pain after
the release of suture on the first postoperative
day. Postoperatively, all patients were given low
potency steroid eye drops four times a day for the
first week and tapered off over six weeks, while
antibiotic drops were administered four times a
day for two weeks. All patients were examined
at week 2 and at months 3, 6, and 12. During
each visit, patients were evaluated for visual acuity,
graft apposition, pain on VAS, complications, and
pterygium recurrence. Recurrence was defined as
any fibrovascular regrowth extending beyond the
surgical limbus involving the cornea.
RESULTS
Both groupswere comparable regarding the demo-
graphic profile [Table 1]. The mean age of patients
was 39.6 ± 11.8 years and 47.3 ± 13.8 years
in RS and SG groups, respectively. The primary
pterygium was present on the right side in the
majority of patients. The predominant type of
pterygium in our study was of Tan’s grade 2 (60%
in RS group and 68% in SG group); while 40%
of patients were of Tan’s grade 1 in RS group;
and 29% of patients were of Tan’s grade 3 in
SG group. The mean duration of surgery in RS
group was 4.84 ± 1.34 min with minimum of 3
min and maximum of 10 min. In SG group, the
mean duration of surgery was 4.90 ± 1.42 min.
In RS group, 36% of patients complained of pain
of scale 2 following the release of suture on the
first postoperative day, while in SG group, 44%
of patients had a pain scale of grade 2. Mean
BCVA before surgery was 0.27 ± 0.41 and 0.22
± 0.33 LogMAR which improved to 0.16 ± 0.28
and 0.16 ± 0.22 LogMAR at 2 weeks after surgery
and was maintained thereafter till the last follow-
up visit in RS and SG groups, respectively. The
maximum area of CAG was 42mm2 in both RS and
SG groups. In SG group, one patient suffered from
the event of graft loss because of eye rubbing. A
second procedure was done on the same day and
a second CAG was derived from the contralateral
eye after obtaining an informed consent from the
patient. While in RS group, eight (5.3%) patients in
whom the CAG was greater than 36mm2, the graft
was retracted by 1 mm from the nasal margin during
the release of the suture on the first postoperative
day, which was successfully repositioned by graft
ironing. In seven (4.6%) patients in the RS group,
there was failed attempt in releasing the suture. In
these patients, the suturewas then cut with Vanna’s
scissor and removed. In six (4 %) patients in the RS
group and three (6.3%) patients in the SG group,
there was a recurrence of grade 1 (conjunctival),
which did not involve the cornea at one year
postoperatively. No patients were lost to follow-
up.
DISCUSSION
From bare sclera technique to mini-simple lim-
bal epithelial transplant,[11] surgical techniques for
pterygium are constantly evolving. The majority of
these techniques require sutures with postopera-
tive suture related complications.[12, 13]
This retrospective comparative study showed
no significant difference in recurrence rate of
pterygium after surgery in RS and SG groups. Both
techniques were equally effective in lowering the
recurrence rate after pterygium surgery. However,
with addition of a simple step of applying a single
RS to the autologous fibrin technique, the surgeon
can be assured of not losing the CAG completely
in cases with graft loss. This is important in patients
coming from low socio-economic strata in develop-
ing countries, where the post operative period is
complicated by a number of factors, especially eye
rubbing.
Compared to sutures, sutureless options such
as fibrin glue, introduced by Koranyi et al,[4] and
autologous blood[14, 15] are more popular adjuvants
for CAG. Although considered safe, the theoretical
potential risk of transmission of infections like
parvovirus-B19, hepatitis B virus, human immune-
deficiency virus, and anaphylaxis in susceptible
individuals make fibrin glue, an “off-label” adjuvant
by Food and Drug Administration (FDA) for the
use in ophthalmology.[14, 16] On the other hand, the
cost of fibrin glue is equal to five sutures mak-
ing it less cost-effective.[16] Improper adherence
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Figure 1. Diagrammatic representation of releasable single suture in situ.
Figure 2. Preoperative and postoperative slit-lamp photograph of patient 1.
of fibrin glue causing graft loss is a recognized
complication.[17, 18] In last few years, several studies
published results of autologous blood as a bio-
logical agent in pterygium surgery. Commercially
available fibrin glue consists of two components
– sealer protein solution (human fibrinogen and
a synthetic fibrinolysis inhibitor, aprotinin) and the
thrombin solution (human thrombin). When mixed
together, these two components combine and
mimic the final stages of natural clotting cascade
to form a cross-linked fibrin clot. Whereas, the
mechanism of action of autologous blood as a
sealant is the natural clotting cascade resulting in
fibrin polymerization. Autologous fibrin is associ-
ated with disadvantages such as graft dehiscence
and graft loss. In these patients with graft loss,
a second surgery is generally required in which
the CAG is retrieved from the fellow eye being
ultimately and reliably affixed by sutures.[19] In
our study, there was one patient in SG group
who suffered graft loss on the first postoperative
day due to eye rubbing. The CAG was then
retrieved from the contralateral eye after proper
counselling and written consent. In contrast, no
event of graft loss occurred in the RS group.
The most important step in patients operated
with RS was releasing the suture on the first
postoperative day. We experienced graft retrac-
tion of 1 mm in eight (5.3%) patients with large
grafts (more than 36 mm2), after the suture was
released. Also, pulling the long end of the RS
posed some difficulty in seven (4.6%) patients,
which was then managed with Vanna’s scis-
sor.
In RS group, the suture helped in proper and
uniform adherence of autograft to the scleral bed
during the immediate postoperative period espe-
cially first 24 h. The mean surgical time in the RS
group was 4.84 ± 1.34 min, while a relatively longer
mean operating time of 4.90 ± 1.42 min in the SG
group was present which was statistically insignifi-
cant (P=0.86). Studies in the past demonstrated the
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Table 1. The details of demographic and other variables in respective groups
VARIABLES CATEGORIES RS GROUP (n = 150)
(RS-Releasable Suture)
SG GROUP (n = 47)
(SG-Sutureless Gluefree)
P-value





> 60 8(5.3%) 8(17%)
Mean age (years) 39.65 ± 11.85 47.36 ± 13.84
GENDER Male 62(41.3%) 25(53.2%) 0.15
Female 88(58.7%) 22(46.8%)
EYE INVOLVED Left 51(34%) 22(46.8%) 0.11
Right 99(66%) 25(53.2%)
PTERYGIUM GRADE 1 60(40%) 1(2.1%)
0.54(TAN et al) 2 90(60%) 32(68.1%)
3 0 14(29.8%)
DURATION OF SURGERY 1-5 109(72.7%) 35(74.4%) 0.86
6-10 41(27.3%) 12(25.5%)
Mean duration (minutes) 4.84 ± 1.34 4.90 ± 1.42
RECURRENCE 6 (4%) 3 (6.3%) 0.495
correlation of surgical time and success of ptery-
gium surgery.[14] More intraoperative time leads
to increased postoperative reaction and leads to
infection.[20] The short time taken to apply a single
RS means more pterygium surgeries in less time.
The pain scale on VASwas consistently less than
2 in all 197 patients on the first postoperative day.
This result is comparable to studies in which fibrin
glue[4] or autologous blood[14, 16] is used. Complica-
tions like serious inflammatory reaction, infection,
corneal ulceration, scleral melting or dellen were
not noticed in any of the patients.
Mitra et al[20] mentioned that once the CAG stays
in place for the first 24–48 h, it is going to stick
around. Thus, the use of single suture for the first
24 h, as a simple additional step to the autologous
fibrin technique, gives a psychological relief to the
operating surgeon. Hirst et al[21] reported that 97%
of pterygium recurrences develop within the first
12 months of surgery. In our study, the conjunctival
recurrence rate was 4% in the RS group and 6.3%
in the SG group, which is comparable to the reports
from other similar studies.
There are several limitations in our study. Firstly,
the retrospective study design has its inherent
limitation. Secondly, a relatively small sample size
of 197 patients. Third, a follow-up period of one
year may not be sufficient to comment on the
efficacy of our technique with respect to the
recurrence. Further evaluation is required to study
the recurrence rate and complications after RS,
with larger sample size and randomized controlled
trials. We recommend that the length of RS over
the graft surface should be adequately long as
governed by the area of CAG. Further studies are
required to find the correlation of suture length
and the area of CAG and its impact on the graft
stability.
In conclusion, in pterygium surgery, RS did
not significantly reduce postoperative pterygium
recurrence. However, in cases with large-sized
CAGs and in patients with increased frequency of
eye rubbing, RS may offer an easy-to-learn and reli-
able method by augmenting the autologous fibrin
mechanism. The postoperative patient comfort is
comparable to the currently accepted standard of
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sutureless gluefree (SG) technique for pterygium
surgery.
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Supplemental video
Video showing technique of application of the
releasable suture.
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